![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Inducible Inflammatory Genes by Interferon-
Is Associated with Altered Nuclear Factor-
B Transactivation and Enhanced Histone Deacetylase ActivityPulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
Airway smooth muscle (ASM) cells can act as effector cells in the initiation and/or perpetuation of airway inflammation in asthma by producing various inflammatory chemokines or cytokines. Previous studies from our laboratory and others showed that the combination of tumor necrosis factor-
(TNF
) and interferon-
(IFN
) or endogenous IFN
results in a synergistic induction of various pro-inflammatory genes, including CD38 and regulated upon activation normal T-cell expressed and secreted (RANTES), in ASM cells. In contrast to these studies, we found that IFN
(1000 U/ml) markedly inhibited TNF
-induced expression of interleukin (IL)-6, IL-8, and eotaxin by 66.29 ± 3.33, 43.86 ± 7.11, and 63.25 ± 6.46%, respectively. These genes were also found to be NF-
B-dependent in that TNF
-induced expression of IL-6, IL-8, and eotaxin was dose-dependently inhibited by the selective IKK
inhibitor 4-(2'-aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline (BMS-345541) (1-30 µM). Using a luciferase reporter construct containing
B sites, we found that IFN
(10-1000 U/ml) inhibits NF-
B-dependent gene transcription in a dose-dependent manner. Moreover, IFN
failed to affect TNF
-induced I
K
phosphorylation or I
B degradation as well as nuclear NF-
B/DNA interaction. It is noteworthy that IFN
decreases TNF
-induced histone acetyl transferase (HAT) and increases histone deacetylase (HDAC) activities. Finally, trichostatin A, an HDAC inhibitor, prevents IFN
inhibitory action on TNF
-induced gene expression. Together, our data indicate that IFN
is a potent inhibitor of specific TNF
-inducible inflammatory genes by acting on NF-
B transactivation via the modulation of HDAC function.
Address correspondence to: Dr. Yassine Amrani, Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, University of Pennsylvania School of Medicine, Translational Research Laboratories Building, Suite 1200, 125 South 31st Street, Philadelphia PA 19104-3403. E-mail: amrani{at}mail.med.upenn.edu
This article has been cited by other articles:
![]() |
O. Tliba, G. Damera, A. Banerjee, S. Gu, H. Baidouri, S. Keslacy, and Y. Amrani Cytokines Induce an Early Steroid Resistance in Airway Smooth Muscle Cells: Novel Role of Interferon Regulatory Factor-1 Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 463 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tliba and Y. Amrani Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways Proceedings of the ATS, January 1, 2008; 5(1): 106 - 112. [Abstract] [Full Text] [PDF] |
||||